IP Library Granted Patent US 6,908,736
Granted Patent B1
US 6,908,736 · App. 10/089,877 · Granted Jun 21, 2005

DNA sequencing method

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 6,908,736
App. No.
10/089,877
Granted
Jun 21, 2005
Kind
B1
Abstract

The present invention pertains to a method for determining the sequence of a polynucleotide, the method relying on the detection of a conformational change in an enzyme that interacts with and processes along the polynucleotide. The detection of a conformational change may be carried out by measuring changes in a fluorophore bound to the enzyme.

Claims (18)

1. A method for determining the sequence of a polynucleotide, comprising the steps of:

i. reacting a target polynucleotide with an enzyme that interacts with and processes along the polynucleotide, under conditions sufficient to induce enzyme activity; and

ii. detecting conformational changes in the enzyme as the enzyme processes along the polynucleotide, and thereby determining the sequence of the polynucleotide;

wherein the enzyme comprises a bound fluorescent molecule, the characteristics of which alter as the enzyme undergoes a conformational change, and wherein the target polynucleotide does not comprise a label prior to, during, or after the enzyme processes along the polynucleotide, and wherein if step (i) is carried out in the presence of polynucleotide monomers, the polynucleotide monomers do not comprise a label.

2. The method according to claim 1 , wherein the enzyme is a polymerase enzyme.

3. The method according to claim 1 , wherein the enzyme is a helicase enzyme or a primase enzyme.

4. The method according to claim 1 , wherein the enzyme is immobilised on a solid support.

5. The method according to claim 4 , comprising a plurality of enzymes immobilised on the solid support.

6. The method according to claim 1 , wherein the enzyme comprises a bound label that interacts with the bound fluorescent molecule, wherein the degree of infraction is dependent on a conformational change in the enzyme.

7. The method according to claim 6 , wherein the bound fluorescent molecule is an energy acceptor and the bound label is an energy donor, or wherein the bound fluorescent molecule is an energy donor and the bound label is an energy acceptor, and wherein step (ii) is carried out by measuring energy transfer between the bound fluorescent molecule and the bound label.

8. The method according to claim 1 , wherein step (ii) is carried out using confocal microscopy.

9. The method according to claim 8 , wherein step (ii) is carried out by fluorescence imaging.

10. The method according to claim 1 , wherein step (ii) is carried out by measuring a polarisation effect consequent on the altered characteristics of the bound fluorescent molecule.

11. The method according to claim 10 , wherein step (ii) is carried out by fluorescence polarisation anisotrophy.

12. A solid support comprising at least one immobilised polymerase or helicase enzyme, the enzyme being labelled with at least one fluorescence resonance energy transfer (FRET) donor label and at least one FRET acceptor label.

13. The solid support according to claim 12 , wherein the at least one fluorescence resonance energy transfer donor label is a fluorophore.

14. A system for determining a sequence of a polynucleotide, comprising a solid support comprising at least one immobilised polymerase or helicase enzyme, the enzyme being labelled with at least one fluorescence resonance energy transfer (FRET) donor label and at least one FRET acceptor label, and an apparatus for detecting the label.

15. The solid support according to claim 12 , wherein the at least one FRET: fluorescence resonance energy transfer acceptor label is a fluorophore.

Assignments (5)
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 028810 FRAME: 0745. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY AGREEMENT. Recorded Nov 9, 2017
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 044432/0565 →
CORRECTIVE ASSIGNMENT TO CORRECT THE INCORRECT PATENT NO. 8081301 PREVIOUSLY RECORDED AT REEL: 035820 FRAME: 0239. ASSIGNOR(S) HEREBY CONFIRMS THE SECURITY INTEREST RELEASE. Recorded Nov 9, 2017
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 044727/0529 →
SECURITY AGREEMENT Recorded Aug 7, 2015
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; DIRECT RADIOGRAPHY CORP.; GEN-PROBE INCORPORATED; GEN-PROBE PRODESSE, INC.; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 036307/0199 →
SECURITY INTEREST RELEASE REEL/FRAME 028810/0745 Recorded Jun 4, 2015
From: GOLDMAN SACHS BANK USA, AS COLLATERAL AGENT
To: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
Reel/Frame 035820/0239 →
SECURITY AGREEMENT Recorded Aug 1, 2012
From: HOLOGIC, INC.; BIOLUCENT, LLC; CYTYC CORPORATION; CYTYC SURGICAL PRODUCTS, LIMITED PARTNERSHIP; SUROS SURGICAL SYSTEMS, INC.; THIRD WAVE TECHNOLOGIES, INC.; GEN-PROBE INCORPORATED
To: GOLDMAN SACHS BANK USA
Reel/Frame 028810/0745 →